vs

Side-by-side financial comparison of ASSOCIATED BANC-CORP (ASB) and Evolent Health, Inc. (EVH). Click either name above to swap in a different company.

Evolent Health, Inc. is the larger business by last-quarter revenue ($468.7M vs $383.0M, roughly 1.2× ASSOCIATED BANC-CORP). ASSOCIATED BANC-CORP runs the higher net margin — 31.2% vs -91.6%, a 122.8% gap on every dollar of revenue. Over the past eight quarters, ASSOCIATED BANC-CORP's revenue compounded faster (9.1% CAGR vs -14.4%).

Associated Banc-Corp is a U.S. regional bank holding company providing retail banking, commercial banking, commercial real estate lending, private banking and specialized financial services. Headquartered in Green Bay, Wisconsin, Associated is a Midwest bank with from more than 220 banking locations serving more than 100 communities throughout Wisconsin, Illinois and Minnesota. The company also operates loan production offices in Indiana, Michigan, Missouri, New York, Ohio and Texas.

Magellan Health Inc., is an American for-profit managed health care company and subsidiary of Centene that focuses on special populations and other specialty areas of healthcare. Magellan's customers include health plans and other managed care organizations, employers, labor unions, various military and governmental agencies and third-party administrators. It ranked 390 on the Fortune 500 in 2021.

ASB vs EVH — Head-to-Head

Bigger by revenue
EVH
EVH
1.2× larger
EVH
$468.7M
$383.0M
ASB
Higher net margin
ASB
ASB
122.8% more per $
ASB
31.2%
-91.6%
EVH
Faster 2-yr revenue CAGR
ASB
ASB
Annualised
ASB
9.1%
-14.4%
EVH

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
ASB
ASB
EVH
EVH
Revenue
$383.0M
$468.7M
Net Profit
$119.6M
$-429.1M
Gross Margin
20.7%
Operating Margin
-87.1%
Net Margin
31.2%
-91.6%
Revenue YoY
-27.5%
Net Profit YoY
566.6%
-1782.0%
EPS (diluted)
$0.70
$-3.76

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ASB
ASB
EVH
EVH
Q1 26
$383.0M
Q4 25
$310.0M
$468.7M
Q3 25
$305.2M
$479.5M
Q2 25
$300.0M
$444.3M
Q1 25
$285.9M
$483.6M
Q4 24
$270.3M
$646.5M
Q3 24
$329.7M
$621.4M
Q2 24
$321.8M
$647.1M
Net Profit
ASB
ASB
EVH
EVH
Q1 26
$119.6M
Q4 25
$137.1M
$-429.1M
Q3 25
$124.7M
$-20.9M
Q2 25
$111.2M
$-19.9M
Q1 25
$101.7M
$-64.6M
Q4 24
$-161.6M
$-22.8M
Q3 24
$88.0M
$-23.1M
Q2 24
$115.6M
$1.6M
Gross Margin
ASB
ASB
EVH
EVH
Q1 26
Q4 25
20.7%
Q3 25
20.8%
Q2 25
22.6%
Q1 25
21.2%
Q4 24
11.7%
Q3 24
13.0%
Q2 24
16.5%
Operating Margin
ASB
ASB
EVH
EVH
Q1 26
Q4 25
52.6%
-87.1%
Q3 25
50.5%
0.2%
Q2 25
46.5%
-0.3%
Q1 25
42.3%
-0.3%
Q4 24
-65.8%
-2.9%
Q3 24
32.8%
-2.6%
Q2 24
32.0%
1.2%
Net Margin
ASB
ASB
EVH
EVH
Q1 26
31.2%
Q4 25
44.2%
-91.6%
Q3 25
40.9%
-4.4%
Q2 25
37.1%
-4.5%
Q1 25
35.6%
-13.4%
Q4 24
-59.8%
-3.5%
Q3 24
26.7%
-3.7%
Q2 24
35.9%
0.2%
EPS (diluted)
ASB
ASB
EVH
EVH
Q1 26
$0.70
Q4 25
$0.80
$-3.76
Q3 25
$0.73
$-0.24
Q2 25
$0.65
$-0.44
Q1 25
$0.59
$-0.63
Q4 24
$-1.10
$-0.26
Q3 24
$0.56
$-0.27
Q2 24
$0.74
$-0.06

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ASB
ASB
EVH
EVH
Cash + ST InvestmentsLiquidity on hand
$151.9M
Total DebtLower is stronger
Stockholders' EquityBook value
$5.0B
$415.2M
Total Assets
$45.6B
$1.9B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ASB
ASB
EVH
EVH
Q1 26
Q4 25
$151.9M
Q3 25
$116.7M
Q2 25
$151.0M
Q1 25
$246.5M
Q4 24
$104.2M
Q3 24
$96.6M
Q2 24
$101.3M
Total Debt
ASB
ASB
EVH
EVH
Q1 26
Q4 25
$1.0B
Q3 25
$594.1M
Q2 25
$593.5M
Q1 25
$591.4M
Q4 24
$1.4B
Q3 24
$844.3M
Q2 24
$536.1M
Stockholders' Equity
ASB
ASB
EVH
EVH
Q1 26
$5.0B
Q4 25
$5.0B
$415.2M
Q3 25
$4.9B
$842.2M
Q2 25
$4.8B
$896.0M
Q1 25
$4.7B
$935.5M
Q4 24
$4.6B
$1.0B
Q3 24
$4.4B
$1.0B
Q2 24
$4.2B
$1.1B
Total Assets
ASB
ASB
EVH
EVH
Q1 26
$45.6B
Q4 25
$45.2B
$1.9B
Q3 25
$44.5B
$2.5B
Q2 25
$44.0B
$2.5B
Q1 25
$43.3B
$2.7B
Q4 24
$43.0B
$2.5B
Q3 24
$42.2B
$2.5B
Q2 24
$41.6B
$2.5B
Debt / Equity
ASB
ASB
EVH
EVH
Q1 26
Q4 25
0.20×
Q3 25
0.12×
Q2 25
0.12×
Q1 25
0.13×
Q4 24
0.31×
Q3 24
0.19×
Q2 24
0.13×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ASB
ASB
EVH
EVH
Operating Cash FlowLast quarter
$48.8M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ASB
ASB
EVH
EVH
Q1 26
Q4 25
$218.1M
$48.8M
Q3 25
$158.0M
$15.8M
Q2 25
$141.5M
$-30.3M
Q1 25
$98.2M
$4.6M
Q4 24
$207.1M
$-26.2M
Q3 24
$105.1M
$18.7M
Q2 24
$113.5M
$21.4M
Cash Conversion
ASB
ASB
EVH
EVH
Q1 26
Q4 25
1.59×
Q3 25
1.27×
Q2 25
1.27×
Q1 25
0.97×
Q4 24
Q3 24
1.19×
Q2 24
0.98×
13.42×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ASB
ASB

Net Interest Income$307.2M80%
Noninterest Income$75.9M20%

EVH
EVH

Commercial And Other Customers$147.9M32%
Medicare Customers$111.2M24%
Specialty Technology And Services Suite$95.7M20%
Administrative Service$55.8M12%
Cases$47.7M10%
Related Party$4.5M1%

Related Comparisons